
Cigna Corporation (CI) – Growth driven by Evernorth segment
in Company Report , HCIT , Healthcare & Life Sciences on September 3, 2021Cigna’s Evernorth segment increased by 13.95%, to $32.59bn for Q2FY21. It was driven by ongoing organic growth, including growth in retail network and specialty pharmacy services.
Highlights
Valuation
– Enterprise Value
– CrispIdea Forecast
– Economic Value Added Analysis
– P/E Analysis
– Peer Valuation
– CrispIdea Forecast Relative to Consensus
– Consensus History and Surprise
– Consensus Momentum
Actual & Historical Performance
– Income Statement
– Balance Sheet
– Cash Flow
– 10 Year Historical Performance
– Ratio Analysis
– Du Pont Analysis
– Segment Performance
– Key Metrics
Peer Performance
– Summary
– Profitability
– Growth
– Price Performance
Ownership
Stock Price Performance
CrispIdea Coverage
No of Pages : 33